Prognostic Implication of NOTCH1 in Early Stage Oral Squamous Cell Cancer with Occult Metastases

Overview

Journal Clin Oral Investig

Specialty Dentistry

Date 2017 Sep 4

PMID 28866747

Citations 12

Authors

Shan Wang

Haixia Fan

Jiankai Xu

Eryang Zhao

Affiliations

Soon will be listed here.

Abstract

Objective: The objective of this study was to explore the prognostic value of cancer stem cell markers, namely CD133, NANOG, and NOTCH1, in early stage oral squamous cell carcinoma (OSCC).

Materials And Methods: One hundred forty-four patients with early stage (cT1T2N0) OSCC were identified from a pre-existing database of patients with oral cancer. We examined the impact of the immunohistochemical expression of CD133, NANOG, and NOTCH1 in OSCC. Overall survival (OS) curves were calculated using the Kaplan-Meier method. Predictors of outcome were identified using multivariate analysis.

Results: We found that CD133, NANOG, and NOTCH1 were significantly associated with lymph node metastasis, and NOTCH1 was also significantly associated with depth of invasion and locoregional recurrence.

Conclusions: NOTCH1 was identified as an independent prognostic factor for OS.

Clinical Relevance: NOTCH1 might prove to be a useful indicator for high-risk patients with occult metastases from early stage OSCC.

Citing Articles

Meta-Analysis of Prognostic Significance of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma.

Tripathi A, Singh M, Mishra P, Fatima N, Kumar V Asian Pac J Cancer Prev. 2024; 25(10):3597-3607.

PMID: 39471027 PMC: 11711375. DOI: 10.31557/APJCP.2024.25.10.3597.

Jiawei Danxuan Koukang Alleviates Arecoline Induced Oral Mucosal Lesions: Network Pharmacology and the Combined Ultra-High Performance Liquid Chromatography (UPLC) and Mass Spectrometry (MS).

Zhou L, Tan J, Dai Y, Zhu K, Xiao Y, Wu D Drug Des Devel Ther. 2023; 17:3085-3101.

PMID: 37854130 PMC: 10581390. DOI: 10.2147/DDDT.S413897.

Detection of NOTCH1 mutations in paraffin samples in patients with potentially malignant lesions.

Baus-Dominguez M, Gomez-Diaz R, Martin-Lozano G, Iglesias-Martin F, Gutierrez-Perez J, Torres-Lagares D J Clin Exp Dent. 2023; 15(3):e177-e186.

PMID: 37008245 PMC: 10062466. DOI: 10.4317/jced.60293.

A γ-Secretase Inhibitor Attenuates Cell Cycle Progression and Invasion in Human Oral Squamous Cell Carcinoma: An In Vitro Study.

Pongjantarasatian S, Nowwarote N, Rotchanakitamnuai V, Srirodjanakul W, Saehun R, Janebodin K Int J Mol Sci. 2022; 23(16).

PMID: 36012128 PMC: 9408752. DOI: 10.3390/ijms23168869.

Ventx Family and Its Functional Similarities with Nanog: Involvement in Embryonic Development and Cancer Progression.

Kumar S, Kumar V, Li W, Kim J Int J Mol Sci. 2022; 23(5).

PMID: 35269883 PMC: 8911082. DOI: 10.3390/ijms23052741.

References

Magee J, Piskounova E, Morrison S . Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell. 2012; 21(3):283-96. PMC: 4504432. DOI: 10.1016/j.ccr.2012.03.003. View

Irollo E, Pirozzi G . CD133: to be or not to be, is this the real question?. Am J Transl Res. 2013; 5(6):563-81. PMC: 3786264. View

Ghuwalewala S, Ghatak D, Das P, Dey S, Sarkar S, Alam N . CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma. Stem Cell Res. 2016; 16(2):405-17. DOI: 10.1016/j.scr.2016.02.028. View

Shrivastava S, Steele R, Sowadski M, Crawford S, Varvares M, Ray R . Identification of molecular signature of head and neck cancer stem-like cells. Sci Rep. 2015; 5:7819. PMC: 4295111. DOI: 10.1038/srep07819. View

Clarke M, Dick J, Dirks P, Eaves C, Jamieson C, Jones D . Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006; 66(19):9339-44. DOI: 10.1158/0008-5472.CAN-06-3126. View

Lee H, Kang Y, Lee J, Byun J, Kim U, Jang S . Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma. BMC Oral Health. 2015; 15(1):153. PMC: 4667499. DOI: 10.1186/s12903-015-0120-9. View

Mucke T, Mitchell D, Wagenpfeil S, Ritschl L, Wolff K, Kanatas A . Incidence and outcome for patients with occult lymph node involvement in T1 and T2 oral squamous cell carcinoma: a prospective study. BMC Cancer. 2014; 14:346. PMC: 4032581. DOI: 10.1186/1471-2407-14-346. View

Arne G, Kristiansson E, Nerman O, Kindblom L, Ahlman H, Nilsson B . Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis. Int J Cancer. 2010; 129(5):1149-61. DOI: 10.1002/ijc.25755. View

Sharma B, Manglik V, OConnell M, Weeraratna A, McCarron E, Broussard J . Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma. Int J Oncol. 2012; 41(5):1570-6. PMC: 3583984. DOI: 10.3892/ijo.2012.1590. View

10.

Fakih A, Rao R, Borges A, Patel A . Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg. 1989; 158(4):309-13. DOI: 10.1016/0002-9610(89)90122-0. View

11.

Lee S, Do S, Lee H, Kang H, Koo B, Lim Y . Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma. Lab Invest. 2016; 96(5):508-16. DOI: 10.1038/labinvest.2015.163. View

12.

Espinoza I, Pochampally R, Xing F, Watabe K, Miele L . Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition. Onco Targets Ther. 2013; 6:1249-59. PMC: 3772757. DOI: 10.2147/OTT.S36162. View

13.

Watanabe M, Ohnishi Y, Inoue H, Wato M, Tanaka A, Kakudo K . NANOG expression correlates with differentiation, metastasis and resistance to preoperative adjuvant therapy in oral squamous cell carcinoma. Oncol Lett. 2013; 7(1):35-40. PMC: 3861537. DOI: 10.3892/ol.2013.1690. View

14.

OBrien C, Pollett A, Gallinger S, Dick J . A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2006; 445(7123):106-10. DOI: 10.1038/nature05372. View

15.

Li Y, Ma J, Qian X, Wu Q, Xia J, Miele L . Regulation of EMT by Notch signaling pathway in tumor progression. Curr Cancer Drug Targets. 2013; 13(9):957-62. DOI: 10.2174/15680096113136660101. View

16.

Yuen A, Ho C, Chow T, Tang L, Cheung W, Ng R . Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck. 2009; 31(6):765-72. DOI: 10.1002/hed.21033. View

17.

Keski-Santti H, Atula T, Tikka J, Hollmen J, Makitie A, Leivo I . Predictive value of histopathologic parameters in early squamous cell carcinoma of oral tongue. Oral Oncol. 2007; 43(10):1007-13. DOI: 10.1016/j.oraloncology.2006.11.015. View

18.

Collins A, Berry P, Hyde C, Stower M, Maitland N . Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005; 65(23):10946-51. DOI: 10.1158/0008-5472.CAN-05-2018. View

19.

Ganly I, Patel S, Shah J . Early stage squamous cell cancer of the oral tongue--clinicopathologic features affecting outcome. Cancer. 2011; 118(1):101-11. DOI: 10.1002/cncr.26229. View

20.

Nakagawa T, Shibuya H, Yoshimura R, Miura M, Okada N, Kishimoto S . Neck node metastasis after successful brachytherapy for early stage tongue carcinoma. Radiother Oncol. 2003; 68(2):129-35. DOI: 10.1016/s0167-8140(03)00187-7. View